Proposed Medicare Coverage Criteria for Cancer Genetic Tests Alarm Industry Stakeholders

Diagnostic industry stakeholders are pushing back against two Medicare Administrative Contractors that have proposed a host of new coverage requirements for cancer genetic tests, including that their use be supported by evidence within third-party databases and practice guidelines.

In a letter signed by 44 organizations, including the Association for Molecular Pathology (AMP), the American College of Medical Genetics and Genomics, and the American Clinical Laboratory Association, stakeholders have raised concerns that the coverage criteria outlined by Novitas and First Coast Service Operations (FCSO) in draft local coverage determinations issued in July would harm Medicare beneficiaries with cancer by hindering their access to genetic tests they need.

Source: https://www.genomeweb.com/cancer/proposed-medicare-coverage-criteria-cancer-genetic-tests-alarm-industry-stakeholders